FR2244481A1 - Oral treatment of diabetes - with a complex of glibenclamide and phenformin - Google Patents

Oral treatment of diabetes - with a complex of glibenclamide and phenformin

Info

Publication number
FR2244481A1
FR2244481A1 FR7432021A FR7432021A FR2244481A1 FR 2244481 A1 FR2244481 A1 FR 2244481A1 FR 7432021 A FR7432021 A FR 7432021A FR 7432021 A FR7432021 A FR 7432021A FR 2244481 A1 FR2244481 A1 FR 2244481A1
Authority
FR
France
Prior art keywords
complex
diabetes
oral treatment
phenformin
glibenclamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7432021A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of FR2244481A1 publication Critical patent/FR2244481A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
FR7432021A 1973-09-21 1974-09-23 Oral treatment of diabetes - with a complex of glibenclamide and phenformin Withdrawn FR2244481A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732347531 DE2347531A1 (de) 1973-09-21 1973-09-21 Arzneizubereitungen zur oralen diabetes-behandlung

Publications (1)

Publication Number Publication Date
FR2244481A1 true FR2244481A1 (en) 1975-04-18

Family

ID=5893251

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7432021A Withdrawn FR2244481A1 (en) 1973-09-21 1974-09-23 Oral treatment of diabetes - with a complex of glibenclamide and phenformin

Country Status (12)

Country Link
JP (1) JPS5053521A (fr)
AU (1) AU7349374A (fr)
BE (1) BE820222A (fr)
DE (1) DE2347531A1 (fr)
DK (1) DK496774A (fr)
FI (1) FI274174A (fr)
FR (1) FR2244481A1 (fr)
IL (1) IL45690A0 (fr)
NL (1) NL7412254A (fr)
NO (1) NO743394L (fr)
SE (1) SE7411852L (fr)
ZA (1) ZA745981B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2816841A1 (fr) * 2000-11-22 2002-05-24 Lipha Nouvelles compositions pharmaceutiques a action antidiabetique et leur procede de preparation
WO2003045355A1 (fr) * 2001-11-29 2003-06-05 Menarini International Operations Luxembourg S.A. Compositions pharmaceutiques comprenant le glibenclamide et la metformine destinees au traitement du diabete sucre de type ii

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61260013A (ja) * 1985-05-14 1986-11-18 Katsumi Takada 三部分からなる多層錠
US5985843A (en) * 1995-04-03 1999-11-16 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition containing sucralfate
MY125516A (en) * 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
US7964216B2 (en) * 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2816841A1 (fr) * 2000-11-22 2002-05-24 Lipha Nouvelles compositions pharmaceutiques a action antidiabetique et leur procede de preparation
WO2002041897A2 (fr) * 2000-11-22 2002-05-30 Lipha S.A. Compositions pharmaceutiques a action antidiabetique constitues de l'association d'un biguanide et d'un sulfonamide
WO2002041879A2 (fr) * 2000-11-22 2002-05-30 Merck Patent Gmbh Nouvelles compositions pharmaceutiques a action antidiabetique et leur procede de preparation
WO2002041879A3 (fr) * 2000-11-22 2003-05-22 Merck Patent Gmbh Nouvelles compositions pharmaceutiques a action antidiabetique et leur procede de preparation
WO2002041897A3 (fr) * 2000-11-22 2003-05-30 Lipha Compositions pharmaceutiques a action antidiabetique constitues de l'association d'un biguanide et d'un sulfonamide
WO2003045355A1 (fr) * 2001-11-29 2003-06-05 Menarini International Operations Luxembourg S.A. Compositions pharmaceutiques comprenant le glibenclamide et la metformine destinees au traitement du diabete sucre de type ii
AU2002358061B2 (en) * 2001-11-29 2007-01-11 Menarini International Operations Luxembourg S.A. Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-II diabetes mellitus

Also Published As

Publication number Publication date
NO743394L (fr) 1975-04-14
NL7412254A (nl) 1975-03-25
FI274174A (fr) 1975-03-22
DE2347531A1 (de) 1975-04-30
AU7349374A (en) 1976-03-25
ZA745981B (en) 1975-10-29
DK496774A (fr) 1975-05-26
SE7411852L (fr) 1975-03-24
IL45690A0 (en) 1974-11-29
BE820222A (fr) 1975-03-24
JPS5053521A (fr) 1975-05-12

Similar Documents

Publication Publication Date Title
NO165540C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse n,n-dimetyl-1-(1-(4-klorfenyl)cyklobutyl)-3-metylbutylamin-hydroklorid-monohydrat.
HK1000913A1 (en) Use of indolone derivatives for the preparation of medicaments for the treatment of parkinsons disease
KR900701261A (ko) 비만증 치료방법
HK129393A (en) Use of gamma-linolenic acid and related compounds for the manufacture of a medicament for the treatment of complications of diabetes mellitus
IL72469A0 (en) Novel insulin derivatives,processes for their preparation and their use,and pharmaceutical agents for the treatment of diabetes mellitus
GB8908085D0 (en) New therapeutic use
MY102565A (en) Novel derivatives of guanine
NO163569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-thioxanthinderivater.
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
CA2179015A1 (fr) Utilisation de bis(amidinobenzimidazoles) dans la fabrication de medicaments destines a inhiber l'integrase retrovirale
FR2244481A1 (en) Oral treatment of diabetes - with a complex of glibenclamide and phenformin
GB1381184A (en) Sulphamides
IE38655L (en) Pharmaceutical compositions
FR2320735A1 (fr) Composition anti-cellulite
MY102991A (en) Medicaments for treating hypertension.
Shanks et al. Stimulation of adrenergic beta-receptors by orciprenaline.
IE46171L (en) N-pyrrolidinylmethylbenzamide derivative.
CA1029305A (fr) Solute de perfusion pour le traitement des tachycardies et mode d'utilisation
FR2447368A1 (fr) Derives de la phenylethylamine, leur preparation et medicament contenant ces substances
NO152253C (no) Analogifremgangsmaate for fremstlling av 4-(n-(3`,4`-dihydroksybenzyliden)aminometyl)-cykloheksan-1-karboksylsyre med terapeutisk aktivitet
AU555496B2 (en) Phenoxypyridine ffor normalizing hippocampal function
EP0227356A3 (en) The use of depogen in the treatment of restricted blood circulation
FR2137186A1 (en) Folic acid salts - used as neuro-stimulants and for dynamising muscular function
GB1375806A (fr)
ES450206A1 (es) Un procedimiento para la preparacion de 1, 2, 3, 4-tetrahi- droisoquinoleinas.

Legal Events

Date Code Title Description
ST Notification of lapse